- Home
- OFRM vs XOMA Comparison
OFRM vs XOMA Comparison
Compare OFRM & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OFRM | XOMA |
|---|---|---|
| Founded | 2015 | 1981 |
| Country | United States | United States |
| Employees | 153 | 14 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 684.3M | 795.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | OFRM | XOMA |
|---|---|---|
| Price | $18.52 | $44.46 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 4 |
| Target Price | $27.75 | ★ $52.50 |
| AVG Volume (30 Days) | ★ 696.2K | 155.8K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $29.42 | $24.59 |
| Revenue Next Year | $34.69 | N/A |
| P/E Ratio | ★ N/A | $29.64 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.00 | $22.29 |
| 52 Week High | $27.00 | $45.22 |
Technical Indicators
Market Signals| Indicator | OFRM | XOMA |
|---|---|---|
| Relative Strength Index (RSI) | 48.40 | 70.97 |
| Support Level | $14.58 | $40.76 |
| Resistance Level | $23.69 | N/A |
| Average True Range (ATR) | 1.65 | 0.68 |
| MACD | -0.41 | 0.20 |
| Stochastic Oscillator | 20.75 | 78.25 |
Price Performance
Historical ComparisonAbout OFRM Once Upon a Farm PBC
Once Upon a Farm PBC is a provider of baby food products. The company provides childhood nutrition with real, organic, farm-fresh food-made with no added sugar, no preservatives, and nothing artificial. Its products are available at retail customers, including Target, Whole Foods, Kroger, Walmart, Publix, and Wegmans. Its key products include Smoothies, Yogurt, Milk Shakes, Oat Bars, etc.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.